USPTO serial 79289155
RHONDA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 12, 2021
- Examiner
- NADELMAN, ANDREA KOYNER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RHONDA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ursula B. Day
Ursula B. Day Law Firm of Ursula B. Day35 West 35th StreetSuite 900New York, NY 10001Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for diagnostic use, namely, laboratory chemicals in the nature of nucleic acid amplification reagents used for the detection of nucleic acids of pathogens for in vitro diagnostic use for scientific purposes, chemical preparations for scientific diagnostic purposes; chemical reagents for chemical analyses for non medical purposes; chemical reagents for use in diagnostic tests, other than for medical or veterinary use; chemical reagents for use in analytical tests, other than for medical or veterinary use; chemical reagents for laboratory use, other than for medical or veterinary use; nucleic acid for use in nucleic acid amplification processes other than for medical or veterinary use; chemicals for use in performing nucleic acid polymerase chain reactions for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; diagnostic reagents for scientific or research use; nucleic acid amplification reagents other than for medical or veterinary use | ACTIVE | — |
| 005 | Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical use; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; reagents for medical use; chemical preparations for testing blood for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical purposes for detecting the presence of pathogenic bacteria, viruses, fungi and parasites; diagnostic preparations and materials, namely, diagnostic preparations for veterinary purposes and diagnostic preparations for medical purposes; clinical diagnostic reagents for medical purposes | ACTIVE | — |
| 009 | Computer hardware and recorded and downloadable software for diagnostic purposes, namely, for operating and configuring blood oxygen saturation processing apparatus for diagnostic tests and displaying apparatus in the nature of computer hardware used for displaying for diagnostic results; mobile apps for diagnostic purposes, namely, downloadable mobile applications for use in data management of diagnostic results and in management of operation of diagnostic apparatus; laboratory apparatus and instruments for diagnostic purposes, namely, analyzers for sample preparation for analyzing blood and other bodily fluids, and for nucleic acid amplification and detection; laboratory instrument for the detection of pathogens and toxins in a biological sample for research use; scientific apparatus and instruments, namely, analyzers for nucleic acid amplification and detection and fluid handling device used for disposable bioprocessing applications and parts and fittings therefor; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids | ACTIVE | — |
| 010 | Apparatus, instruments and equipment for diagnostic purposes, namely, diagnostic apparatus for the detection of pathogenic bacteria, viruses, fungi and parasites as well as their resistances; automatic analyzers for medical diagnosis, namely, nucleic acid amplification and detection apparatus; analyzers for bacterial identification for medical purposes; apparatus for analyzing bacteria in biological samples for medical use; automated analyzers for body fluids for medical use in the nature of medical diagnostic instruments for the analysis of body fluids; automated analyzers for foreign matter contained in body fluids for medical use in the nature of medical diagnostic instruments for the analysis of pathogenic bacteria, viruses, fungi and parasites as well as their resistances contained in body fluids; automated analyzers for pathogenic bacteria, viruses, fungi and parasites as well as their resistances contained in body fluids for medical use in the nature of medical diagnostic instruments for the analysis of pathogenic bacteria, viruses, fungi and parasites as well as their resistances contained in body fluids; electronic analyzers for medical purposes, namely, apparatus for nucleic acid amplification and detection for medical diagnostics; photometric and fluorescence-based analyzers of nucleic acid amplification reactions for medical use; physical analyzers of pathogenic bacteria, viruses, fungi and parasites for medical use; genetic testing apparatus for medical purposes in the nature of apparatus for nucleic acid testing for medical purposes; blood testing apparatus; apparatus for blood analysis for medical use; automated analyzers in the nature of nucleic acid analyzers for medical diagnostic uses; diagnostic apparatus for medical purposes, namely, for testing for pathogenic bacteria, viruses, fungi and parasites; analyzers for medical use, namely, medical instruments for analyzing and identifying pathogenic bacteria, viruses, fungi and parasites; medical apparatus and instruments for detecting pathogenic bacteria, viruses, fungi and parasites; diagnostic test kits comprised of enzymes, oligonucleotides and further nucleic acid amplification and detection reagents for detecting the existence of multi-resistant germs in human body fluids and of blood disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Spindiag GmbH
- Other trademarks owned by Spindiag GmbH
- Other trademarks owned by Spindiag GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named RHONDA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 12, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 17, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 17, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 12, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 12, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 27, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 27, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 24, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 7, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 7, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 7, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 24, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 24, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 24, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 24, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 19, 2021 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Apr 19, 2021 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Apr 19, 2021 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Apr 5, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 5, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Feb 4, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 4, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 4, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 18, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 18, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 18, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 18, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 18, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 5, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 20, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 20, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 15, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 13, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 10, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 9, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |